Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NIH 7OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 294Neoplasms 221Prostatic Neoplasms 178Colorectal Neoplasms 125Lung Neoplasms 121Carcinoma, Non-Small-Cell Lung 108Leukemia, Myeloid, Acute 92Pancreatic Neoplasms 84Multiple Myeloma 76Precursor Cell Lymphoblastic Leukemia-Lymphoma 64Squamous Cell Carcinoma of Head and Neck 63Carcinoma, Hepatocellular 62Head and Neck Neoplasms 60Glioblastoma 60Brain Neoplasms 58Neoplasm Metastasis 54Melanoma 51Uterine Cervical Neoplasms 47Carcinoma, Renal Cell 46Rectal Neoplasms 45Stomach Neoplasms 44Ovarian Neoplasms 44Hematologic Neoplasms 44Myelodysplastic Syndromes 39Triple Negative Breast Neoplasms 38Motor Activity 38Esophageal Neoplasms 36Colonic Neoplasms 36Urinary Bladder Neoplasms 35Recurrence 34

Interventions

talazoparib 1irinotecan sucrosofate 1Temozolomide 1Liquid Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Neuroectodermal Tumors, Primitive, Peripheral × 30 days × Clear all
NCT04901702 2026-05-19

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
90 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

NCT06068075 2026-05-05

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

Dana-Farber Cancer Institute

Phase NA Active not recruiting
340 enrolled
Sarcoma

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡